Philip Morris is expected to report Q1 2026 revenue of $9.93 billion and an adjusted EPS of $1.82, with shares currently trading at $158.12 against an average analyst price target of $195.72. The primary focus for investors is the shipment volume of ZYN nicotine pouches in the U.S., as the company navigates increased regulatory scrutiny and tough year-over-year comparisons.
Analysts are watching for signs that the smoke-free segment, which now accounts for over 40% of total revenue, can sustain its growth trajectory despite a managed decline in combustible cigarette volumes. Additionally, this quarter marks the debut of a new three-segment reporting structure, which is expected to provide greater transparency into regional margins and the scale of the company's domestic smoke-free business.